Effects of Low Doses of Pioglitazone on Resting-State Functional Connectivity in Conscious Rat Brain

Pioglitazone (PIO) is a peroxisome proliferator-activated receptor-γ (PPARγ) agonist in clinical use for treatment of type 2 diabetes (T2DM). Accumulating evidence suggests PPARγ agonists may be useful for treating or delaying the onset of Alzheimer’s disease (AD), possibly via actions on mitochondr...

Descripción completa

Detalles Bibliográficos
Autores principales: Crenshaw, Donna G., Asin, Karen, Gottschalk, William K., Liang, Zhifeng, Zhang, Nanyin, Roses, Allen D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324644/
https://www.ncbi.nlm.nih.gov/pubmed/25671601
http://dx.doi.org/10.1371/journal.pone.0117973

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324644/
https://www.ncbi.nlm.nih.gov/pubmed/25671601
http://dx.doi.org/10.1371/journal.pone.0117973

Ejemplares similares